CRA consultants Ann Baker, Matthew Majewski, and Andrew Parece provide insight on various life sciences innovation topics including breaking barriers and creating value. Their comments appear in the April 2016 Celebrating Innovation special issue of PharmaVOICE. To read more, click the link below.
Part 4: Inflation Reduction Act: The indirect effects and implications of IRA price negotiations
Since passage of the Inflation Reduction Act (IRA) in August 2022, the focus of many industry analysts and pharmaceutical companies has been on two important...